Children's Hospital Los Angeles

The lab-developed test will use Thermo Fisher Scientific's Ion sequencing platform and will be applicable to most childhood cancers. 

The consortium is composed of six children's hospitals including Children's Hospital Los Angeles; Rady Children's Hospital, San Diego; and Children's Hospital Colorado.

The new gene panel is based on DNA and RNA sequencing research and will utilize Thermo's Ion Torrent platform and Ion AmpliSeq technology.

The new investment will go towards the areas of cancer, inherited diseases, and infectious diseases, with an initial focus on pediatric cancer.

WaferGen Biosystems and collaborators in the laboratory of Jo Vandesompele at the University of Ghent have developed a PCR-based target enrichment workflow using WaferGen's SmartChip real-time PCR system, the company said this week.

The group expects delivery of two Ion PGMs by the end of the month, and will use them for "targeted, clinically relevant studies," said Timothy Triche, director of the center for personalized medicine at Children's Hospital Los Angeles.

Timothy Triche will use the award to establish a next-generation sequencing core facility to study high-risk childhood cancer.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.